CLEVELAND, Sept. 25, 2018 /PRNewswire/ -- ViewRay, Inc.
(NASDAQ: VRAY) announced today that members of the executive
management team are scheduled to present at the Cantor Global
Healthcare Conference in New York,
NY.
Event: 2018 Cantor Global Healthcare
Conference
Date: Tuesday, October 2,
2018
Time: 2:15pm ET
An audio webcast of the Company's presentation will be available
on the investor relations section of ViewRay's website at
www.viewray.com. A replay of the webcast will be available for 7
days after the date of the presentation.
About ViewRay
ViewRay®, Inc. (Nasdaq: VRAY),
designs, manufactures and markets the MRIdian® radiation therapy
system. MRIdian is built upon a proprietary high-definition MR
imaging system designed from the ground up to address the unique
challenges and clinical workflow for advanced radiation oncology.
Unlike MR systems used in diagnostic radiology, MRIdian's
high-definition MR was purposely built to deliver high-precision
radiation without unnecessary beam distortion, and consequently,
help to mitigate skin toxicity and other safety concerns that may
otherwise arise when high magnetic fields interact with radiation
beams. ViewRay and MRIdian are registered trademarks
of ViewRay, Inc.
View original
content:http://www.prnewswire.com/news-releases/viewray-to-present-at-the-2018-cantor-global-healthcare-conference-300718186.html
SOURCE ViewRay, Inc.